DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Richardson PG, Barlogie B, Berenson J. et al.
A phase 2 study of bortezomib in relapsed, refractory myeloma. 
N Engl J Med 2003; 348: 2609-2617  

Download Bibliographical Data

Access:
Access:
Access: